Treatment of the ventricular tachycardia with engraftment of pluripotent stem cells-derived cardiomyocytes

Journal of Molecular and Cellular Cardiology

Volumn 53, Issue 1, 2012, Pages 3-5

  Fujita, Jun ^a   Sano, Motoaki ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; CONNEXIN 43; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR2.1; PLACEBO; SODIUM CHANNEL NAV1.5; TRANSFORMING GROWTH FACTOR BETA;

ARRHYTHMOGENESIS; BIOGENESIS; CATHETER ABLATION; CELL DIFFERENTIATION; CELLULAR IMMUNITY; DEFIBRILLATOR; DISEASE CLASSIFICATION; DISEASE SEVERITY; EDITORIAL; ELECTRIC SHOCK; EMBRYONIC STEM CELL; EPIGENETICS; GENE MUTATION; HEART CONDUCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE; HEART MUSCLE CELL; HEART VENTRICLE TACHYCARDIA; HISTOCOMPATIBILITY; HUMAN; HUMORAL IMMUNITY; LONG QT SYNDROME; MYOBLAST; PIGMENT EPITHELIUM; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REGENERATIVE MEDICINE; REPORTER GENE; STEM CELL TRANSPLANTATION; SURVIVAL RATE;

ANIMALS; ARRHYTHMIAS, CARDIAC; ELECTROPHYSIOLOGICAL PROCESSES; EMBRYONIC STEM CELLS; HUMANS; MYOCYTES, CARDIAC;

EID: 84861984478     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2012.04.002     Document Type: Editorial

References (29)

1. Stehlik J., Edwards L.B., Kucheryavaya A.Y., Benden C., Christie J.D., Dobbels F., et al. The Registry of the International Society for Heart and Lung Transplantation: Twenty-eighth Adult Heart Transplant Report - 2011. J Heart Lung Transplant 2011, 30:1078-1094.
2. Strauer B.-E., Steinhoff G. 10 Years of Intracoronary and Intramyocardial Bone Marrow Stem Cell Therapy of the Heart: From the Methodological Origin to Clinical Practice. J Am Coll Cardiol 2011, 58:1095-1104.
3. Menasché P., Alfieri O., Janssens S., McKenna W., Reichenspurner H., Trinquart L., et al. The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) Trial. Circulation 2008, 117:1189-1200.
4. Veltman C.E., Soliman O.I.I., Geleijnse M.L., Vletter W.B., Smits P.C., ten Cate F.J., et al. Four-year follow-up of treatment with intramyocardial skeletal myoblasts injection in patients with ischaemic cardiomyopathy. Eur Heart J 2008, 29:1386-1396.
5. Bolli R., Chugh A.R., D'Amario D., Loughran J.H., Stoddard M.F., Ikram S., et al. Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial. Lancet 2011, 378:1847-1857.
6. Thomson J.A., Itskovitz-Eldor J., Shapiro S.S., Waknitz M.A., Swiergiel J.J., Marshall V.S., et al. Embryonic Stem Cell Lines Derived from Human Blastocysts. Science 1998, 282:1145-1147.
7. Schwartz S.D., Hubschman J.P., Heilwell G., Franco-Cardenas V., Pan C.K., Ostrick R.M., et al. Embryonic stem cell trials for macular degeneration: a preliminary report. Lancet 2012, 379:713-720.
8. Takahashi K., Tanabe K., Ohnuki M., Narita M., Ichisaka T., Tomoda K., et al. Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors. Cell 2007, 131:861-872.
9. Yu J., Vodyanik M.A., Smuga-Otto K., Antosiewicz-Bourget J., Frane J.L., Tian S., et al. Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells. Science 2007, 318:1917-1920.
10. Seki T., Yuasa S., Oda M., Egashira T., Yae K., Kusumoto D., et al. Generation of Induced Pluripotent Stem Cells from Human Terminally Differentiated Circulating T Cells. Cell Stem Cell 2010, 7:11-14.
11. Okita K., Hong H., Takahashi K., Yamanaka S. Generation of mouse-induced pluripotent stem cells with plasmid vectors. Nat Protoc 2010, 5:418-428.
12. Ichida J.K., Blanchard J., Lam K., Son E.Y., Chung J.E., Egli D., et al. A Small-Molecule Inhibitor of Tgf-β Signaling Replaces Sox2 in Reprogramming by Inducing Nanog. Cell Stem Cell 2009, 5:491-503.
13. Mummery C. Induced pluripotent stem cells-a cautionary note. N Engl J Med 2011, 364:2160-2162.
14. Hattori F., Chen H., Yamashita H., Tohyama S., Satoh Y.-s., Yuasa S., et al. Nongenetic method for purifying stem cell-derived cardiomyocytes. Nat Meth 2010, 7:61-66.
15. Di Stasi A., Tey S.K., Dotti G., Fujita Y., Kennedy-Nasser A., Martinez C., et al. Inducible Apoptosis as a Safety Switch for Adoptive Cell Therapy. N Engl J Med 2011, 365:1673-1683.
16. Laflamme M.A., Chen K.Y., Naumova A.V., Muskheli V., Fugate J.A., Dupras S.K., et al. Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat Biotechnol 2007, 25:1015-1024.
17. Tulloch N.L., Muskheli V., Razumova M.V., Korte F.S., Regnier M., Hauch K.D., et al. Growth of Engineered Human Myocardium With Mechanical Loading and Vascular Coculture / Novelty and Significance. Circ Res 2011, 109:47-59.
18. Kehat I., Gepstein A., Spira A., Itskovitz-Eldor J., Gepstein L. High-Resolution Electrophysiological Assessment of Human Embryonic Stem Cell-Derived Cardiomyocytes. Circ Res 2002, 91:659-661.
19. Zhang J., Wilson G.F., Soerens A.G., Koonce C.H., Yu J., Palecek S.P., et al. Functional Cardiomyocytes Derived From Human Induced Pluripotent Stem Cells. Circ Res 2009, 104:e30-e41.
20. Gepstein L., Ding C., Rehemedula D., Wilson E.E., Yankelson L., Caspi O., et al. In Vivo Assessment of the Electrophysiological Integration and Arrhythmogenic Risk of Myocardial Cell Transplantation Strategies. Stem Cells 2010, 28:2151-2161.
21. Thompson S.A., Burridge P.W., Lipke E.A., Shamblott M., Zambidis E.T., Tung L. Engraftment of human embryonic stem cell derived cardiomyocytes improves conduction in an arrhythmogenic in vitro model. J Mol Cell Cardiol 2012, 53:15-23.
22. Yang B., Lin H., Xiao J., Lu Y., Luo X., Li B., et al. The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2. Nat Med 2007, 13:486-491.
23. Hosoda T., Zheng H., Cabral-da-Silva M., Sanada F., Ide-Iwata N., Ogórek B., et al. Human Cardiac Stem Cell Differentiation Is Regulated by a Mircrine Mechanism / Clinical Perspective. Circulation 2011, 123:1287-1296.
24. Thompson S.A., Copeland C.R., Reich D.H., Tung L. Mechanical Coupling Between Myofibroblasts and Cardiomyocytes Slows Electric Conduction in Fibrotic Cell Monolayers / Clinical Perspective. Circulation 2011, 123:2083-2093.
25. Investigators A.V.I.D. A Comparison of Antiarrhythmic-Drug Therapy with Implantable Defibrillators in Patients Resuscitated from Near-Fatal Ventricular Arrhythmias. N Engl J Med 1997, 337:1576-1584.
26. Bardy G.H., Lee K.L., Mark D.B., Poole J.E., Packer D.L., Boineau R., et al. Amiodarone or an Implantable Cardioverter-Defibrillator for Congestive Heart Failure. N Engl J Med 2005, 352:225-237.
27. Reddy V.Y., Reynolds M.R., Neuzil P., Richardson A.W., Taborsky M., Jongnarangsin K., et al. Prophylactic Catheter Ablation for the Prevention of Defibrillator Therapy. N Engl J Med 2007, 357:2657-2665.
28. Jonsson M.K., Vos M.A., Mirams G.R., Duker G., Sartipy P., de Boer T.P., et al. Application of human stem cell-derived cardiomyocytes in safety pharmacology requires caution beyond hERG. J Mol Cell Cardiol 2012, 52:998-1008.
29. Moretti A., Bellin M., Welling A., Jung C.B., Lam J.T., Bott-Flügel L., et al. Patient-Specific Induced Pluripotent Stem-Cell Models for Long-QT Syndrome. N Engl J Med 2010, 363:1397-1409.